Could a simple inhaler prevent deadly pneumonia in ventilator patients?
NCT ID NCT07409727
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests whether inhaling a medicine called N-acetylcysteine (NAC) can prevent pneumonia in critically ill patients who need a breathing machine. About 80 adults on ventilators will receive either NAC or a placebo. Researchers will track how many develop pneumonia and how long it takes, along with other breathing and infection measures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATION ACQUIRED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University Hospitals
RECRUITINGCairo, 11011, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.